XALKORI 250 MG 60 CAPS

It is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma neuroblastoma and other advanced solid tumors in both adults and children.